Fred Hutch’s Dr. Eric Holland collaborates with Dana-Farber on promising mouse study
Feb. 6, 2014
| By Kristen Woodward
An altered radiation treatment schedule for the most common and lethal form of brain cancer has been shown to extend the survival period of mice with the disease, which suggests that some alteration in schedule may be able to do the same for human patients.
Study links patient, tumor characteristics with breaks in radiotherapy that could cure
Sept. 28, 2009
Medicare recipients with head and neck cancers commonly do not complete radiation therapy without interruptions, or at all. A study led by Fred Hutchinson Cancer Research Center scientists addresses why.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.